DUBLIN--(BUSINESS WIRE)--The "Healthcare Contract Research Organization (CRO) Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-Clinical, Clinical), By Service, By Region, And Segment Forecasts, 2018 - 2024" report has been added to ResearchAndMarkets.com's offering.
The global healthcare contract research organization (CRO) market is expected to reach USD 51.3 billion by 2024
Increasing drug development cost is expected to drive market demand over the forecast period. With the increasing number of patents expiring, increasing number of partnerships to identify biologics and new compounds and growing R&D costs, drug maker and sponsor companies are under pressure to replace the revenue loss specifically due to generics, which has further made drug development more expensive and complex.
Moreover, owing to the increasing incidence rates of chronic diseases such as cancer, Alzheimer's and other infectious diseases in children, government funding has increased, which have led to increasing R&D activities. For instance, in January 2015, the U.S. announced an investment of USD 215 million for precision medicine initiative. The investment was broken up for NIH (USD 130 million), NCI (USD 70 million), and FDA (USD 10 million).
In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing of research activities. Even government organizations are outsourcing their clinical trial activities to CROs so that they can carry out the clinical trials with the required infrastructure, expertise, and minimize cost and timelines. In 2015, the Canadian Federal Budget made an investment of USD 1.33 billion for the Canada Foundation for Innovation (CFI).
Key Topics Covered:
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Healthcare Contract Research Organization (CRO) Industry Outlook
Chapter 4 Healthcare Contract Research Organization (CRO) Market Outlook by Type
Chapter 5 Healthcare Contract Research Organization (CRO) Market Outlook by Service
Chapter 6 Healthcare Contract Research Organization (CRO), Regional Outlook
Chapter 7 Competitive Landscape
- Pharmaceutical Product Development, LLC (PPD)
- Charles River Laboratories (CRL)
- ICON, Plc
- Medidata Solutions
- inVentiv Health
- Theorem Clinical research
For more information about this report visit https://www.researchandmarkets.com/research/mxf2qk/global_healthcare?w=4